Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers

Clinical trial NCT02140996 · UNKNOWN

Trial details

NCT number: NCT02140996
Sponsor: Singapore Clinical Research Institute
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Epithelial Cancers of the Lung, Breast, Ovary, Prostate and Colon

Start date: 2014-09-01
Primary completion: 2017-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.